Pharmaceutical manufacturers Sanofi, GlaxoSmithKline (GSK) and Viatris are fully or partially exempting additional states from their 340B contract pharmacy restrictions. [...] …
Category: Providers
The U.S. government is urging a federal appeals court to dismiss a lower court’s “erroneous” decision to dismiss a California [...] …
New legislation introduced in the U.S. House of Representatives would extend 340B program eligibility to qualifying hospitals in all five [...] …
Federal lawmakers may soon vote on a bipartisan bill to streamline Medicaid enrollment for pediatric providers that would also require [...] …
Two major national 340B provider advocacy groups are stepping up their criticisms of the 340B ACCESS Act, arguing that the [...] …
Two 340B hospitals urged a federal district court to block drugmaker Johnson & Johnson (J&J) from conducting “unlawfully authorized” audits [...] …
New Jersey-based drug manufacturing giant Merck and a large Wisconsin-based health system are the latest to join the 340B Working [...] …
Just days after a federal court in Mississippi denied Novartis’ attempt to block the state’s 340B contract pharmacy access law, [...] …
Health System Urges Federal Appeals Court to Revive 340B Overcharge Lawsuit Against Major Drugmakers
A California health system has urged a federal appeals court to reverse a lower court’s decision to dismiss its lawsuit [...] …
Merck will loosen its 340B contract pharmacy restrictions in Minnesota and Missouri, becoming the first drugmaker to officially update its [...] …